From International Ethics to European Union Policy: A Case Study on Biopiracy in the EU's Biotechnology Directive

Published date01 July 2006
AuthorEMILIE CLOATRE
Date01 July 2006
DOIhttp://doi.org/10.1111/j.1467-9930.2006.00230.x
LAW & POLICY, Vol. 28, No. 3, July 2006 ISSN 0265–8240
© 2006 The Author
Journal compilation © 2006 Baldy Center for Law and Social Policy
Blackwell Publishing LtdOxford, UKLAPOLaw & Policy0265-8240© 2006 Baldy Center for Law and Social PolicyJuly 2006283
Original ArticleLAW & POLICY July 2006Cloatre BIOPIRACY IN THE EU’s BIOTECHNOLOGY DIRECTIVE
From International Ethics to European Union
Policy: A Case Study on Biopiracy in the EU’s
Biotechnology Directive
EMILIE CLOATRE
This article explores how the question of biopiracy, and the rights of indigenous
people in the context of patents over natural resources related to traditional
knowledge became articulated within the European Union’s law and policy process.
It presents how this issue was first introduced into the EU during the negotiation
on the Directive 98/44/EC, and which mechanisms transformed this ethical issue
into a policy concern. Analyzing the history of this issue within that of Directive
98/44/EC offers significant opportunities for testing the appropriateness of multi-
level governance and policy-network theories to empirical sociolegal research in
the EU context.
I. INTRODUCTION
The European Union’s Directive 98/44/EC on the Legal Protection of Biotech-
nological Inventions is a text of essential importance for biotechnology in the
EU from both a legal and a socio-ethical point of view. The focus of this article
is on one aspect of the Biotechnology Directive: the provision concerning
“biopiracy” and the rights of indigenous people in the context of patents
over natural resources related to traditional knowledge. The article seeks to
explore how the question of biopiracy became articulated within the EU’s
law and policymaking processes. Tracing the history of the negotiation of the
Biotechnology Directive also offers significant opportunities for demonstrating
how specific empirical research can be best explained through the use of multi-
level governance and policy-networks theories.
This article is based on a MA thesis submitted in September 2002 at the University of Nottingham,
UK, Institute for Genetics, Biorisks and Society. Many thanks to Professor Tamara K. Hervey
for her supervision and support during my MA, and her help with this article. I am also very grateful
to Dr. Paul Martin for his co-supervision during my MA and Professor Robert Dingwall for
his help with this article. Thanks also to all those who were interviewed during this research.
Address correspondence to Emilie Cloatre, Institute for the Study of Genetics, Biorisk,
and Society, Law & Social Science Building, West Wing, University of Nottingham,
University Park, Nottingham NG7 2RD, UK. Telephone: +44 (0) 115 84 67618; e-mail:
emilie.cloatre@nottingham.ac.uk
346
LAW & POLICY July 2006
© 2006 The Author
Journal compilation © 2006 Baldy Center for Law and Social Policy
For many years, the biotechnological industry has complained of not having
an appropriate and harmonized patent protection in the EU. Directive 98/44/
EC constituted the legal answer to this demand. However, the debate on the
legal protection of biotechnological inventions raised many ethical issues.
For this reason, the directive took almost ten years to be adopted. In addition,
in the EU system, a directive is a legal text adopted as compulsory guidelines
for Member States, but which needs to be transposed into national law within
a specific deadline. Transposition of the text at national level created further
debates within Member States.
Directive 98/44/EC has been discussed by many commentators in relation
to the crucial ethical issues it raises. Most debates have revolved in particular
around issues of “patenting on life,” and relative to the status of the human body.
However, other important ethical issues also appeared during the debates
on the directive, and these have sometimes been forgotten in later discussion.
One of those is the patenting of elements linked to traditional knowledge and
genetic resources from developing countries. This issue has been urgently
debated within developing countries, and at the international level, where
legal frameworks have been developed to try to remedy some of the local
concerns. However, in 1998 it was a fairly new issue on the European scene.
Considering the evolution of this matter from an ethical issue to a policy con-
cern, and identifying the factors that participated in this evolution, opened
interesting perspectives for empirical testing of theories of policymaking.
Several specialized NGOs outlined the importance of biopiracy during the
negotiations and provoked a real debate on the question. The first concrete
outcome of their work was a parliamentary proposal integrating an article
aimed at reducing risks of biopiracy, as will be explained below. The proposed
article, however, was not integrated as such in the modified proposal sub-
mitted by the European Commission, and the final outcome of the debates
was the integration of a similar disposition in a non-binding recital. Even if
this result appears to be of limited legal effect, the simple fact that the question
was debated in Europe and even generated some parliamentary proposals
is of real importance in terms of the integration of the issue on the EU
policy agenda. In particular, the limited acknowledgement of the issue of
biopiracy in intellectual property law in the EU, as well as the strong inter-
national legal barriers existing in the area, appeared to be significant limits
to interest groups’ hopes for reform.
By presenting the ways in which biopiracy was considered during the
negotiation on Directive 98/44/EC, and how this issue became embodied
into political discourses and into the final text of the directive, this article will
highlight how multilevel governance approaches and policy-network theory are
both highly complementary and valuable in empirical analysis of EU policy-
making. The need to analyse policymaking in the EU as a dynamic process
at several levels—supranational and national, official and unofficial—in order
to include all relevant elements in empirical research will be emphasized, and
the importance of multilevel governance in that regard will be highlighted.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT